These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 10368813)
1. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells. Ware JH; Wan XS; Kennedy AR Nutr Cancer; 1999; 33(2):174-7. PubMed ID: 10368813 [TBL] [Abstract][Full Text] [Related]
2. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Chen YW; Huang SC; Lin-Shiau SY; Lin JK Carcinogenesis; 2005 Jul; 26(7):1296-306. PubMed ID: 15746161 [TBL] [Abstract][Full Text] [Related]
3. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells. Zhang L; Wan XS; Donahue JJ; Ware JH; Kennedy AR Nutr Cancer; 1999; 33(2):165-73. PubMed ID: 10368812 [TBL] [Abstract][Full Text] [Related]
4. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate. Wan XS; Serota DG; Ware JH; Crowell JA; Kennedy AR Nutr Cancer; 2002; 43(2):167-73. PubMed ID: 12588697 [TBL] [Abstract][Full Text] [Related]
5. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity. Malkowicz SB; Liu SP; Broderick GA; Wein AJ; Kennedy AR; Levin RM Neurourol Urodyn; 2003; 22(1):54-7. PubMed ID: 12478602 [TBL] [Abstract][Full Text] [Related]
6. Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells. Wan XS; Hamilton TC; Ware JH; Donahue JJ; Kennedy AR Nutr Cancer; 1998; 31(1):8-17. PubMed ID: 9682243 [TBL] [Abstract][Full Text] [Related]
7. Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum. Kennedy CW; Donahue JJ; Wan XS Nutr Cancer; 1996; 26(2):209-17. PubMed ID: 8875558 [TBL] [Abstract][Full Text] [Related]
8. Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type of protease inhibitors. Yavelow J; Caggana M; Beck KA Cancer Res; 1987 Mar; 47(6):1598-601. PubMed ID: 3545448 [TBL] [Abstract][Full Text] [Related]
9. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate. Kennedy AR; Szuhaj BF; Newberne PM; Billings PC Nutr Cancer; 1993; 19(3):281-302. PubMed ID: 8346077 [TBL] [Abstract][Full Text] [Related]
10. Effects of Bowman-Birk inhibitor on rat colon carcinogenesis. Kennedy AR; Billings PC; Wan XS; Newberne PM Nutr Cancer; 2002; 43(2):174-86. PubMed ID: 12588698 [TBL] [Abstract][Full Text] [Related]
11. Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43. Saito T; Sato H; Virgona N; Hagiwara H; Kashiwagi K; Suzuki K; Asano R; Yano T Cancer Lett; 2007 Aug; 253(2):249-57. PubMed ID: 17343982 [TBL] [Abstract][Full Text] [Related]
12. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor. Billings PC; Habres JM; Liao DC; Tuttle SW Cancer Res; 1991 Oct; 51(20):5539-43. PubMed ID: 1913672 [TBL] [Abstract][Full Text] [Related]
13. Studies related to the potential antigenicity of the Bowman-Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans. Maki PA; Paterson Y; Kennedy AR Nutr Cancer; 1994; 22(2):185-93. PubMed ID: 14502847 [TBL] [Abstract][Full Text] [Related]
14. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia. Armstrong WB; Kennedy AR; Wan XS; Atiba J; McLaren CE; Meyskens FL Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):43-7. PubMed ID: 10667462 [TBL] [Abstract][Full Text] [Related]
15. Bowman-Birk protease inhibitor activates DNA-dependent protein kinase and reduces formation of radiation-induced dicentric chromosomes. Dittmann K; Virsik-Köpp P; Mayer C; Rave-Fränk M; Rodemann HP Int J Radiat Biol; 2003 Oct; 79(10):801-8. PubMed ID: 14630539 [TBL] [Abstract][Full Text] [Related]
16. Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29. Fereidunian A; Sadeghalvad M; Oscoie MO; Mostafaie A Arch Med Res; 2014 Aug; 45(6):455-61. PubMed ID: 25014623 [TBL] [Abstract][Full Text] [Related]
17. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390 [TBL] [Abstract][Full Text] [Related]
18. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent. Ekrami H; Kennedy AR; Witschi H; Shen WC J Drug Target; 1993; 1(1):41-9. PubMed ID: 8069543 [TBL] [Abstract][Full Text] [Related]
19. Potential intracellular target proteins of the anticarcinogenic Bowman Birk protease inhibitor identified by affinity chromatography. Billings PC; St Clair W; Owen AJ; Kennedy AR Cancer Res; 1988 Apr; 48(7):1798-802. PubMed ID: 3280120 [TBL] [Abstract][Full Text] [Related]
20. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor. St Clair WH; Billings PC; Carew JA; Keller-McGandy C; Newberne P; Kennedy AR Cancer Res; 1990 Feb; 50(3):580-6. PubMed ID: 2297699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]